Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ESTA | US
0.59
1.32%
Healthcare
Medical Devices
30/06/2024
04/10/2024
45.25
42.20
45.43
41.77
Establishment Labs Holdings Inc. a medical technology company manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander a breast tissue expander. The company sells its products through distributors and direct sales force in Europe the Middle East Latin America and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela Costa Rica.
View LessStrength based on increasing price with high volume
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
113.4%1 month
81.1%3 months
72.2%6 months
64.0%-
-
29.20
4.39
0.69
-26.29
9.63
-
-56.36M
1.26B
1.26B
-
-21.18
-
-9.20
-166.58
27.28
24.25
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
12.68
Range1M
12.68
Range3M
18.91
Rel. volume
1.08
Price X volume
23.70M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
AtriCure Inc | ATRC | Medical Instruments & Supplies | 27.63 | 1.35B | -0.25% | n/a | 16.30% |
Integra LifeSciences Holdings Corporation | IART | Medical Devices | 17 | 1.32B | -1.85% | 61.62 | 130.98% |
INMODE LTD. | INMD | Medical Devices | 15.78 | 1.20B | 2.20% | 10.08 | 0.00% |
BioLife Solutions Inc | BLFS | Medical Instruments & Supplies | 24.54 | 1.13B | 1.03% | n/a | 11.19% |
ARTIVION INC | AORT | Medical Devices | 26.44 | 1.11B | 0.34% | n/a | 122.90% |
Pulse Biosciences Inc | PLSE | Medical Instruments & Supplies | 15.98 | 979.42M | -3.33% | n/a | 32.05% |
Perspective Therapeutics Inc. | CATX | Medical Devices | 13.35 | 900.16M | 1.06% | n/a | 0.00% |
MiMedx Group Inc | MDXG | Medical Devices | 5.76 | 845.62M | -0.69% | 10.23 | 11.46% |
Embecta Corp | EMBC | Medical Instruments & Supplies | 13.51 | 779.55M | -3.08% | 11.80 | -216.41% |
Alphatec Holdings Inc | ATEC | Medical Instruments & Supplies | 5.49 | 771.13M | 4.57% | n/a | 1364.44% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Redfin Corporation | RDFN | Real Estate Services | 11.11 | 1.35B | -5.12% | n/a | -8279.77% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 5.75 | 1.12B | 1.23% | n/a | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
FRP Holdings Inc | FRPH | Real Estate Services | 30.13 | 573.39M | 2.27% | 74.92 | 42.65% |
HOUS | HOUS | Real Estate Services | 5.03 | 559.70M | -5.27% | n/a | 201.36% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
The RMR Group Inc | RMR | Real Estate Services | 25.49 | 426.32M | 1.27% | 16.38 | 14.14% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -26.29 | 45.99 | Cheaper |
Ent. to Revenue | 9.63 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 29.20 | 6.06 | Expensive |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 72.20 | 66.08 | Par |
Debt to Equity | 4.39 | 0.83 | Expensive |
Debt to Assets | 0.69 | 0.28 | Expensive |
Market Cap | 1.26B | 9.42B | Emerging |